{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:08:17Z","timestamp":1785305297105,"version":"3.55.0"},"reference-count":51,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ40373"],"award-info":[{"award-number":["2023JJ40373"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Projects of Hunan Provincial Health Commission","award":["B202309026144"],"award-info":[{"award-number":["B202309026144"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The BRAF V600E mutation was proven associated with papillary thyroid cancer (PTC) which has more aggressive behavior and could affect the outcome of PTC. The objective of this study was to observe more contrast-enhanced ultrasound (CEUS) time-intensity curve (TIC)\u2014based quantitative parameters in nodules and surrounding parenchyma and analyze the association between the TIC-based quantitative parameters and BRAF V600E mutation status in patients with PTC.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A retrospective analysis of 447 PTC patients was conducted. Prior to thyroidectomy or fine needle aspiration (FNA), all patients had CEUS and had their BRAF V600E mutations examined. Based on their mutation status, the patients were split into two groups. The two groups were compared in terms of sex, age, quantitative CEUS characteristics, pathological findings, vascular invasion, capsular invasion, and cervical lymph node metastases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 240 patients were in the mutation negative group and 207 patients were in the BRAF mutation positive group. The BRAF-positive group exhibited significantly higher arrival time (AT) and time to peak enhancement (TTP) of the nodules, among other direct quantitative characteristics. The BRAF-positive mutant nodules showed significantly higher arrival time change and time to peak change compared to the surrounding parenchyma for indirect quantitative metrics.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The time-dependent quantitative parameters of CEUS time intensity curve in nodules and surrounding parenchyma have clinical value in distinguishing BRAF V600E mutation positive nodules from gene mutation negative nodules. Quantitative CEUS characteristics may be beneficial in detecting the BRAF V600E mutation status and informing the subsequent clinical choice.<\/jats:p>\n<\/jats:sec>","DOI":"10.7717\/peerj.19006","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T08:36:32Z","timestamp":1740472592000},"page":"e19006","source":"Crossref","is-referenced-by-count":3,"title":["Role of contrast-enhanced ultrasound with time-intensity curve analysis about thyroid nodule and parenchyma for differentiating BRAF V600E mutation status"],"prefix":"10.7717","volume":"13","author":[{"given":"Zhipeng","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Ultrasound Medicine, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheli","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"1","key":"10.7717\/peerj.19006\/ref-1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000322365","article-title":"Thyroid cytopathology: Bethesda and beyond","volume":"55","author":"Ali","year":"2011","journal-title":"Acta Cytologica"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocrine Pathology"},{"issue":"3","key":"10.7717\/peerj.19006\/ref-3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/RUQ.0000000000000406","article-title":"The association among quantitative contrast-enhanced ultrasonography features, thyroid imaging reporting and data system and BRAF V600E mutation status in patients with papillary thyroid microcarcinoma","volume":"35","author":"Chen","year":"2019","journal-title":"Ultrasound Quarterly"},{"key":"10.7717\/peerj.19006\/ref-4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/cam4.4419","article-title":"BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: clinical correlations for 4600 patients","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Medicine"},{"issue":"10","key":"10.7717\/peerj.19006\/ref-5","first-page":"339","article-title":"Surgical treatment of papillary thyroid carcinoma without lymph nodal involvement","volume":"33","author":"Conzo","year":"2012","journal-title":"IL Giornale Di Chirurgia"},{"key":"10.7717\/peerj.19006\/ref-6","author":"Delellis","year":"2004","journal-title":"World Health Organization classification classification of tumours: pathology and genetics of tumours of endocrine organs"},{"issue":"6","key":"10.7717\/peerj.19006\/ref-7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.21037\/tcr.2017.09.15","article-title":"Quantification of solid hypo-echoic thyroid nodule enhancement with contrast-enhanced ultrasound","volume":"6","author":"Diao","year":"2017","journal-title":"Original Article on Translational Imaging in Cancer Patient Care"},{"key":"10.7717\/peerj.19006\/ref-8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fendo.2023.1240615","article-title":"Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules","volume":"14","author":"Fan","year":"2024","journal-title":"Frontiers in Endocrinology"},{"key":"10.7717\/peerj.19006\/ref-9","doi-asserted-by":"publisher","first-page":"783670","DOI":"10.3389\/fendo.2021.783670","article-title":"Value of contrast-enhanced ultrasound in partially cystic papillary thyroid carcinomas","volume":"12","author":"Fang","year":"2021","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Communications"},{"issue":"7","key":"10.7717\/peerj.19006\/ref-11","doi-asserted-by":"publisher","first-page":"e2323500","DOI":"10.1001\/jamanetworkopen.2023.23500","article-title":"Facilitation of definitive cancer diagnosis with quantitative molecular assays of BRAF V600E and TERT promoter variants in patients with thyroid nodules","volume":"6","author":"Fu","year":"2023","journal-title":"JAMA Network Open"},{"issue":"S1","key":"10.7717\/peerj.19006\/ref-12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12902-019-0367-2","article-title":"Calcitonin negative medullary thyroid carcinoma: a challenging diagnosis or a medical dilemma?","volume":"19","author":"Gambardella","year":"2019","journal-title":"BMC Endocrine Disorders"},{"issue":"3","key":"10.7717\/peerj.19006\/ref-13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4158\/EP.16.3.468","article-title":"American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations","volume":"16","author":"Gharib","year":"2013","journal-title":"Endocrine Practice"},{"issue":"4","key":"10.7717\/peerj.19006\/ref-14","first-page":"4","article-title":"The clinical diagnosis of follicular variant of papillary thyroid carcinoma and its research progress of molecular biology","volume":"38","author":"Haoran","year":"2017","journal-title":"Shanghai Medical & Pharmaceutical Journal (2017)"},{"key":"10.7717\/peerj.19006\/ref-15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2015","journal-title":"Thyroid"},{"key":"10.7717\/peerj.19006\/ref-16","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1210\/jc.2003-030305","article-title":"Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers","volume":"9","author":"Hiroyuki","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.7717\/peerj.19006\/ref-17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ultrasmedbio.2016.05.011","article-title":"An algorithm of image heterogeneity with contrast-enhanced ultrasound in differential diagnosis of solid thyroid nodules","volume":"43","author":"Jin","year":"2017","journal-title":"Ultrasound in Medicine & Biology"},{"issue":"7","key":"10.7717\/peerj.19006\/ref-18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1089\/thy.2018.0541","article-title":"Impact of extranodal extension on risk stratification in papillary thyroid carcinoma","volume":"29","author":"Kim","year":"2019","journal-title":"Thyroid"},{"issue":"7","key":"10.7717\/peerj.19006\/ref-19","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/cncr.26500","article-title":"The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer","volume":"118","author":"Kim","year":"2012","journal-title":"Cancer"},{"issue":"11","key":"10.7717\/peerj.19006\/ref-20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41574-020-00414-9","article-title":"Understanding the ever-changing incidence of thyroid cancer","volume":"16","author":"Kitahara","year":"2020","journal-title":"Nature Reviews Endocrinology"},{"issue":"4","key":"10.7717\/peerj.19006\/ref-21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.4143\/crt.2016.424","article-title":"Genetic alterations and their clinical implications in high-recurrence risk papillary thyroid cancer","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Research and Treatment"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/cncr.22754","article-title":"Clinicopathologic significance ofBRAF V600E mutation in papillary carcinomas of the thyroid","volume":"110","author":"Lee","year":"2007","journal-title":"Cancer"},{"issue":"9957","key":"10.7717\/peerj.19006\/ref-23","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/S0140-6736(14)62242-X","article-title":"Overdiagnosis and screening for thyroid cancer in Korea","volume":"384","author":"Lee","year":"2014","journal-title":"The Lancet Journal"},{"key":"10.7717\/peerj.19006\/ref-24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis\u2014ScienceDirect","author":"Li","year":"2020","journal-title":"Lancet Diabetes and Endocrinology"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/thy.2017.0129","article-title":"European perspective on 2015 American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: proceedings of an interactive international symposium","volume":"29","author":"Luster","year":"2019","journal-title":"Thyroid"},{"key":"10.7717\/peerj.19006\/ref-26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.31344\/IJHHS.V3I4.106","article-title":"The prevalence and prognostic value of BRAFV600E mutation in papillary thyroid cancer","volume":"3","author":"Maaitah","year":"2019","journal-title":"International Journal of Human and Health Sciences"},{"issue":"2","key":"10.7717\/peerj.19006\/ref-27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1210\/jc.2016-2555","article-title":"Germline polymorphisms of the VEGF-pathway predict recurrence in non-advanced differentiated thyroid cancer","volume":"102","author":"Marotta","year":"2016","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10.7717\/peerj.19006\/ref-28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/1389202915999140404101257","article-title":"Application of molecular diagnostics to the evaluation of the surgical approach to thyroid cancer","volume":"15","author":"Miccoli","year":"2014","journal-title":"Current Genomics"},{"issue":"4","key":"10.7717\/peerj.19006\/ref-29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"The Lancet. Diabetes & endocrinology"},{"issue":"5","key":"10.7717\/peerj.19006\/ref-30","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/cncr.24118","article-title":"High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes","volume":"115","author":"Oler","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8229445","article-title":"Contrast-enhanced ultrasonography for differential diagnosis of benign and malignant thyroid lesions: single-institutional prospective study of qualitative and quantitative CEUS characteristics","volume":"2022","author":"Petrasova","year":"2022","journal-title":"Contrast Media & Molecular Imaging"},{"issue":"21","key":"10.7717\/peerj.19006\/ref-32","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1158\/1078-0432.CCR-21-2138","article-title":"Molecular pathways and mechanisms of BRAF in cancer therapy","volume":"28","author":"Poulikakos","year":"2022","journal-title":"Clinical Cancer Research"},{"key":"10.7717\/peerj.19006\/ref-33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/thy.2011.0431","article-title":"Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension","volume":"22","author":"Ricarte-Filho","year":"2012","journal-title":"Thyroid"},{"key":"10.7717\/peerj.19006\/ref-34","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1530\/EJE-16-0202","article-title":"Advances in molecular pathogenesis of thyroid cancer","volume":"175","author":"Riesco-Eizaguirre","year":"2016","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1148\/radiol.212319","article-title":"A practical CEUS thyroid reporting system for thyroid nodules","volume":"305","author":"Ruan","year":"2022","journal-title":"Radiology"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40463-021-00543-9","article-title":"BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas \u2264 1.5 cm","volume":"50","author":"Silver","year":"2021","journal-title":"Journal of Otolaryngology\u2014Head & Neck Surgery"},{"key":"10.7717\/peerj.19006\/ref-37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3892\/etm.2016.3344","article-title":"Contrast-enhanced ultrasound and real-time elastography in the differential diagnosis of malignant and benign thyroid nodules","volume":"12","author":"Sui","year":"2016","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"4","key":"10.7717\/peerj.19006\/ref-38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11547-019-01129-2","article-title":"Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference","volume":"125","author":"Trimboli","year":"2020","journal-title":"La Radiologia Medica"},{"issue":"5","key":"10.7717\/peerj.19006\/ref-39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/MD.0b013e31826a9c71","article-title":"BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis","volume":"91","author":"Tufano","year":"2012","journal-title":"Medicine"},{"key":"10.7717\/peerj.19006\/ref-40","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.2147\/CMAR.S299157","article-title":"Value of combining clinical factors, conventional ultrasound, and contrast-enhanced ultrasound features in preoperative prediction of central lymph node metastases of different sized papillary thyroid carcinomas","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Management and Research"},{"key":"10.7717\/peerj.19006\/ref-41","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/SLA.0000000000003074","article-title":"Is less more? A microsimulation model comparing cost-effectiveness of the revised American thyroid association\u2019s 2015 to 2009 guidelines for the management of patients with thyroid nodules and differentiated thyroid cancer","volume":"271","author":"White","year":"2020","journal-title":"Annals of Surgery"},{"key":"10.7717\/peerj.19006\/ref-42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fonc.2020.00112","article-title":"Differentiation of thyroid nodules difficult to diagnose with contrast-enhanced ultrasonography and real-time elastography","volume":"10","author":"Xi","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"10.7717\/peerj.19006\/ref-43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"310","author":"Xing","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","article-title":"Association between BRAF V600E mutation and recurrence of papillary thyroid cancer","volume":"33","author":"Xing","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"9871","key":"10.7717\/peerj.19006\/ref-45","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(13)60109-9","article-title":"Progress in molecular-based management of differentiated thyroid cancer\u2014ScienceDirect","volume":"381","author":"Xing","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.7717\/peerj.19006\/ref-46","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1507\/endocrj.ej14-0275","article-title":"Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy","volume":"61","author":"Yamada","year":"2014","journal-title":"Endocrine Journal"},{"issue":"11","key":"10.7717\/peerj.19006\/ref-47","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.21037\/qims.2018.12.08","article-title":"Ultrasound molecular imaging for differentiation of benign and malignant tumors in patients","volume":"8","author":"Yan","year":"2018","journal-title":"Quantitative Imaging in Medicine and Surgery"},{"issue":"9","key":"10.7717\/peerj.19006\/ref-48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.19347\/j.cnki.2096-1413.201809068","article-title":"Value of contrast-enhanced ultrasound in the clinical management of papillary thyroid microcarcinoma","volume":"3","author":"Yong-Heng","year":"2018","journal-title":"Clinical Research and Practice. 2018"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0973-1482.147382","article-title":"Contrast-enhanced ultrasound in the diagnosis of solitary thyroid nodules","volume":"11","author":"Yuan","year":"2015","journal-title":"Journal of Cancer Research & Therapeutics"},{"issue":"1","key":"10.7717\/peerj.19006\/ref-50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/thy.2009.0045","article-title":"Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules","volume":"20","author":"Zhang","year":"2010","journal-title":"Thyroid"},{"key":"10.7717\/peerj.19006\/ref-51","doi-asserted-by":"publisher","first-page":"e0231775","DOI":"10.1371\/journal.pone.0231775","article-title":"Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: an updated meta-analysis with comprehensive heterogeneity analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"PLOS ONE"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/19006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19006.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19006.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T08:36:40Z","timestamp":1740472600000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/19006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":51,"alternative-id":["10.7717\/peerj.19006"],"URL":"https:\/\/doi.org\/10.7717\/peerj.19006","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"article-number":"e19006"}}